Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
Work
Year: 2020
Type: article
Abstract: Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure or death from cardiovascular causes among patients with stable heart failure. However, the safety... more
Source: New England Journal of Medicine
Authors Deepak L. Bhatt, Michael Szarek, Philippe Gabríel Steg, Christopher P. Cannon, Lawrence A. Leiter +14 more
Institutions Brigham and Women's Hospital, Harvard University, SUNY Downstate Health Sciences University, State University of New York, University of Colorado Anschutz Medical Campus +24 more
Cites: 51
Cited by: 1,506
Related to: 10
FWCI: 188.3
Citation percentile (by year/subfield): 99.99
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze
Funder Sanofi